Nuclear Receptors Nomenclature Committee (1999). "A unified nomenclature system for the nuclear receptor superfamily". Cell97 (2): 161–3. PMID10219237. doi:10.1016/S0092-8674(00)80726-6.
Laudet V (1997). "Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor". J. Mol. Endocrinol.19 (3): 207–26. PMID9460643. doi:10.1677/jme.0.0190207.
Escriva H, Langlois MC, Mendonça RL, Pierce R, Laudet V (May 1998). "Evolution and diversification of the nuclear receptor superfamily". Annals of the New York Academy of Sciences839: 143–6. PMID9629140. doi:10.1111/j.1749-6632.1998.tb10747.x.
Overington JP, Al-Lazikani B, Hopkins AL (2006). "How many drug targets are there?". Nature reviews. Drug discovery5 (12): 993–6. PMID17139284. doi:10.1038/nrd2199.
Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V (2006). "International Union of Pharmacology. LXVI. Orphan nuclear receptors". Pharmacol. Rev.58 (4): 798–836. PMID17132856. doi:10.1124/pr.58.4.10.
Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F (March 2013). "Multidomain integration in the structure of the HNF-4α nuclear receptor complex". Nature495 (7441): 394–398. PMID23485969. doi:10.1038/nature11966.
Lou X, Toresson G, Benod C, Suh JH, Philips KJ, Webb P, Gustafsson JA (February 2014). "Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA". Nat. Struct. Mol. Biol.21 (3): 277–281. PMID24561505. doi:10.1038/nsmb.2778.
Copland JA, Sheffield-Moore M, Koldzic-Zivanovic N, Gentry S, Lamprou G, Tzortzatou-Stathopoulou F, Zoumpourlis V, Urban RJ, Vlahopoulos SA (June 2009). "Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?". BioEssays31 (6): 629–41. PMID19382224. doi:10.1002/bies.200800138.
Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene GL, Gustafsson J-Å, Carlquist M (1997). "Molecular basis of agonism and antagonism in the oestrogen receptor". Nature389 (6652): 753–8. PMID9338790. doi:10.1038/39645.
Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998). "The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen". Cell95 (7): 927–37. PMID9875847. doi:10.1016/S0092-8674(00)81717-1.
Gronemeyer H, Gustafsson JA, Laudet V (2004). "Principles for modulation of the nuclear receptor superfamily". Nature reviews. Drug discovery3 (11): 950–64. PMID15520817. doi:10.1038/nrd1551.
Busch BB, Stevens WC Jr, Martin R, Ordentlich P, Zhou S, Sapp DW, Horlick RA, Mohan R (2004). "Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha". J. Med. Chem.47 (23): 5593–6. PMID15509154. doi:10.1021/jm049334f.
Smith CL, O'Malley BW (2004). "Coregulator function: a key to understanding tissue specificity of selective receptor modulators". Endocr Rev25 (1): 45–71. PMID14769827. doi:10.1210/er.2003-0023.
Pascual G, Glass CK (2006). "Nuclear receptors versus inflammation: mechanisms of transrepression". Trends Endocrinol Metab17 (8): 321–7. PMID16942889. doi:10.1016/j.tem.2006.08.005.
Wu W, Niles EG, El-Sayed N, Berriman M, LoVerde PT (2006). "Schistosoma mansoni (Platyhelminthes, Trematoda) nuclear receptors: sixteen new members and a novel subfamily". Gene366 (2): 303–15. PMID16406405. doi:10.1016/j.gene.2005.09.013.
Nuclear Receptors Nomenclature Committee (1999). "A unified nomenclature system for the nuclear receptor superfamily". Cell97 (2): 161–3. PMID10219237. doi:10.1016/S0092-8674(00)80726-6.
Laudet V (1997). "Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor". J. Mol. Endocrinol.19 (3): 207–26. PMID9460643. doi:10.1677/jme.0.0190207.
Escriva H, Langlois MC, Mendonça RL, Pierce R, Laudet V (May 1998). "Evolution and diversification of the nuclear receptor superfamily". Annals of the New York Academy of Sciences839: 143–6. PMID9629140. doi:10.1111/j.1749-6632.1998.tb10747.x.
Overington JP, Al-Lazikani B, Hopkins AL (2006). "How many drug targets are there?". Nature reviews. Drug discovery5 (12): 993–6. PMID17139284. doi:10.1038/nrd2199.
Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V (2006). "International Union of Pharmacology. LXVI. Orphan nuclear receptors". Pharmacol. Rev.58 (4): 798–836. PMID17132856. doi:10.1124/pr.58.4.10.
Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F (March 2013). "Multidomain integration in the structure of the HNF-4α nuclear receptor complex". Nature495 (7441): 394–398. PMID23485969. doi:10.1038/nature11966.
Lou X, Toresson G, Benod C, Suh JH, Philips KJ, Webb P, Gustafsson JA (February 2014). "Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA". Nat. Struct. Mol. Biol.21 (3): 277–281. PMID24561505. doi:10.1038/nsmb.2778.
Copland JA, Sheffield-Moore M, Koldzic-Zivanovic N, Gentry S, Lamprou G, Tzortzatou-Stathopoulou F, Zoumpourlis V, Urban RJ, Vlahopoulos SA (June 2009). "Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?". BioEssays31 (6): 629–41. PMID19382224. doi:10.1002/bies.200800138.
Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene GL, Gustafsson J-Å, Carlquist M (1997). "Molecular basis of agonism and antagonism in the oestrogen receptor". Nature389 (6652): 753–8. PMID9338790. doi:10.1038/39645.
Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998). "The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen". Cell95 (7): 927–37. PMID9875847. doi:10.1016/S0092-8674(00)81717-1.
Gronemeyer H, Gustafsson JA, Laudet V (2004). "Principles for modulation of the nuclear receptor superfamily". Nature reviews. Drug discovery3 (11): 950–64. PMID15520817. doi:10.1038/nrd1551.
Busch BB, Stevens WC Jr, Martin R, Ordentlich P, Zhou S, Sapp DW, Horlick RA, Mohan R (2004). "Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha". J. Med. Chem.47 (23): 5593–6. PMID15509154. doi:10.1021/jm049334f.
Smith CL, O'Malley BW (2004). "Coregulator function: a key to understanding tissue specificity of selective receptor modulators". Endocr Rev25 (1): 45–71. PMID14769827. doi:10.1210/er.2003-0023.
Pascual G, Glass CK (2006). "Nuclear receptors versus inflammation: mechanisms of transrepression". Trends Endocrinol Metab17 (8): 321–7. PMID16942889. doi:10.1016/j.tem.2006.08.005.
Wu W, Niles EG, El-Sayed N, Berriman M, LoVerde PT (2006). "Schistosoma mansoni (Platyhelminthes, Trematoda) nuclear receptors: sixteen new members and a novel subfamily". Gene366 (2): 303–15. PMID16406405. doi:10.1016/j.gene.2005.09.013.